Zura Bio Ltd (ZURA) concluded trading on Wednesday at a closing price of $4.13, with 3.15 million shares of worth about $13.02 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 34.09% during that period and on September 18, 2024 the price saw a gain of about 6.44%. Currently the company’s common shares owned by public are about 43.59M shares, out of which, 32.94M shares are available for trading.
Stock saw a price change of 18.00% in past 5 days and over the past one month there was a price change of 18.68%. Year-to-date (YTD), ZURA shares are showing a performance of -11.56% which decreased to -33.23% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.00 but also hit the highest price of $7.22 during that period. The average intraday trading volume for Zura Bio Ltd shares is 333.96K. The stock is currently trading 9.24% above its 20-day simple moving average (SMA20), while that difference is up 12.02% for SMA50 and it goes to 7.06% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zura Bio Ltd (NASDAQ: ZURA) currently have 43.59M outstanding shares and institutions hold larger chunk of about 43.82% of that.
The stock has a current market capitalization of $263.37M and its 3Y-monthly beta is at 0.16. It has posted earnings per share of -$0.51 in the same period. It has Quick Ratio of 12.57 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZURA, volatility over the week remained 8.46% while standing at 8.60% over the month.
Stock’s fiscal year EPS is expected to rise by 75.60% while it is estimated to decrease by -36.27% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on September 05, 2024 offering a Neutral rating for the stock and assigned a target price of $5 to it. Coverage by Piper Sandler stated Zura Bio Ltd (ZURA) stock as an Overweight in their note to investors on May 03, 2024, suggesting a price target of $26 for the stock. On October 10, 2023, Ladenburg Thalmann Initiated their recommendations, while on August 25, 2023, Oppenheimer Initiated their ratings for the stock with a price target of $17. Stock get a Buy rating from Guggenheim on June 22, 2023.
